Chromacare aims to revolutionize precision health through Mobile-based At-home Lab Tests. To the end, over the next 12 months, commencing in early 2024, Chromacare will develop up to three novel quantitative Lateral Flow Assays (LFA) that will be measured with our proprietary Chromacare App. We will employ two Chemistry PhD graduates on a full-time basis […]
Read More